|
시장보고서
상품코드
2070324
진단용 이비인후과 기기 시장 규모와 예측(2021-2034년), 세계 및 지역별 점유율, 동향, 성장 기회 분석 보고서 범위 : 종류별, 용도별, 최종사용자별, 지역별Diagnostic ENT Devices Market Size and Forecast 2021 - 2034, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Application, End User, and Geography |
||||||
진단용 이비인후과 기기 시장 규모는 2025년 104억 2,000만 달러에서 2034년까지 61억 달러로 확대될 것으로 예상됩니다. 2026년부터 2034년까지 CAGR 6.0%를 기록할 것으로 전망됩니다.
인간 의료 분야에서 다제내성 그람음성균 감염증의 증가와 가축·가금류 사육 분야에서 지속되는 수의학적 수요는 이비인후과 진단 기기 시장의 확대에 기여하는 주목할 만한 요인입니다. 또한, 항생제 내성에 대응하기 위한 규제 변경 및 정책, 그리고 전문적인 이비인후과 의료 서비스의 확대가 가까운 시일 내에 시장에 새로운 동향을 가져올 것으로 예상됩니다.
세계보건기구(WHO, 2024년)에 따르면, 전 세계적으로 4억 3,000만 명 이상이 일상생활에 지장을 줄 정도의 난청으로 고통받고 있으며, 이 수치는 고령화와 환경적 위험 요인으로 인해 크게 증가할 것으로 예상됩니다. WHO 보고서에 따르면, 전 세계적으로 15억 명 이상이 어느 정도의 청력 손실을 겪고 있으며, 이는 가장 널리 퍼진 감각 기관 관련 건강 문제 중 하나입니다. 60세 이상 인구의 약 25%가 청각 장애로 고통받고 있으며, 노화와 이비인후과 질환 사이에 강한 연관성이 있다는 사실이 부각되고 있습니다.
미국 국립 청각 및 기타 의사소통 장애 연구소(NIDCD)의 보고에 따르면, 65세에서 74세 사이의 성인 중 약 22%가 일상생활에 지장을 줄 정도의 난청을 앓고 있으며, 고령층에서 그 유병률은 급격히 증가하고 있습니다. WHO의 추산에 따르면, 전 세계적으로 3,400만 명의 어린이가 청력 손실로 고통받고 있으며, 그 대부분은 예방 가능한 감염병이나 출산 시 합병증이 원인입니다. 선진국과 개발도상국을 막론하고 이러한 유병률의 증가에 따라, 조기 발견 및 임상 진단에 사용되는 청력계, 고막압 측정기, 내시경 영상 진단 시스템 등 진단용 이비인후과 기기에 대한 수요가 높아지고 있습니다.
용도별 시장 동향
용도별 시장 세분화에서는 시장이 이비인후과, 비과, 후두과 및 기타 용도로 분류됩니다. 2025년에는 병원 약국 부문이 가장 큰 시장 점유율을 차지했습니다. 이비인후과 진단 기기 시장 중 이과학 분야는 청력 장애, 중이염, 그리고 전문적인 진단 평가가 필요한 노화성 청력 장애의 유병률 증가에 따라 성장하고 있습니다. 세계보건기구(WHO, 2024년)에 따르면, 전 세계적으로 15억 명 이상이 어느 정도의 청력 장애를 겪고 있으며, 그중 상당수가 이비인후과적 평가와 치료가 필요합니다. CDC의 임상 데이터(2024년)에 따르면, 중이염은 여전히 소아 감염증 중 가장 흔한 질환 중 하나이며, 외래 진료 시 진단용 이경 검사나 고막 측정이 빈번하게 필요합니다. FDA의 규제 개정(2023-2025년)에 따르면, 첨단 디지털 이경, 중이 진단 시스템 및 휴대용 청력 검사 기기의 승인으로 인해 청각 장애의 조기 발견이 향상되고 임상적 의사결정이 신속해졌습니다. 또한, 동료 심사를 거친 이과학 연구(2025년)에서는 전음성 난청 및 감각신경성 난청의 조기 발견을 위해 고해상도 고막 영상 진단 및 AI를 활용한 청력 평가 도구의 사용이 증가하고 있다는 점이 강조되고 있습니다. 2023년부터 2025년까지 신생아 청력 선별 검사 프로그램의 확대와 고령화에 따른 수요 증가로 인해, 병원 및 전문 클리닉에서 이비인후과 진단 시스템에 대한 의존도가 더욱 높아지고 있습니다.
목차
제1장 주요 요약
제2장 진단용 이비인후과 기기 시장 시장 구도
제3장 경쟁 구도
제4장 진단용 이비인후과 기기 시장 - 주요 시장 역학
제5장 진단용 이비인후과 기기 시장 - 세계 시장 분석
제6장 진단용 이비인후과 기기 시장 매출 분석 : 종류별
제7장 2034년까지 진단용 이비인후과 시장 매출 분석 : 이비인후과용 내시경
제8장 진단용 이비인후과 기기 시장 매출 분석 : 용도별
제9장 진단용 이비인후과 기기 시장 매출 분석 : 최종사용자
제10장 진단용 이비인후과 기기 시장 - 지역 분석
제11장 진단용 이비인후과 기기 시장 : 업계 상황
제12장 진단용 이비인후과 기기 시장 - 주요 기업 개요
제13장 기타 분석 대상 기업 리스트
제14장 부록
KSMThe Diagnostic ENT Devices market size is expected to grow from US$ 10.42 billion in 2025 to US$ 6.10 billion by 2034; it is projected to register a CAGR of 6.0% during 2026-2034.
The increased multidrug-resistant Gram-negative infections in human healthcare, sustained veterinary demand in livestock and poultry farming are noteworthy factors contributing to the expansion of the Diagnostic ENT Devices market. Additionally, the regulatory shifts and policies addressing antimicrobial resistance as well as expansion of specialized ENT healthcare services are projected to bring new market drifts in the near future.
According to the World Health Organization (WHO, 2024), more than 430 million people worldwide suffer from disabling hearing loss, a figure expected to rise significantly due to aging populations and environmental risk factors. WHO reports that over 1.5 billion people globally experience some degree of hearing loss, making it one of the most widespread sensory health conditions. Nearly 25% of individuals above 60 are affected by hearing impairment, highlighting the strong link between aging and ENT disorders.
In the US, the National Institute on Deafness and Other Communication Disorders (NIDCD) reports that approximately 22% of adults aged 65-74 have disabling hearing loss, with prevalence increasing sharply in older populations. WHO estimates that 34 million children globally are affected by hearing loss, often due to preventable infections or birth complications. These rising prevalence rates across developed and developing regions are increasing demand for diagnostic ENT devices such as audiometers, tympanometers, and endoscopic imaging systems used for early detection and clinical diagnosis.
Application Channel -Based Insights
By application, the market is segmented into otology, rhinology, laryngology, and other applications. The hospital pharmacy segment held the largest market share in 2025. The otology segment in the diagnostic ENT devices market is growing due to the increasing prevalence of hearing loss, middle ear infections, and age-related auditory disorders requiring specialized diagnostic evaluation. According to the World Health Organization (WHO, 2024), over 1.5 billion people globally live with some degree of hearing loss, with a significant proportion requiring otologic assessment and intervention. According to CDC clinical data (2024), otitis media remains one of the most common pediatric infections, frequently requiring diagnostic otoscopy and tympanometry in outpatient settings. According to FDA regulatory updates (2023-2025), approvals for advanced digital otoscopes, middle ear diagnostic systems, and portable audiology devices have improved early detection of auditory disorders and enabled faster clinical decision-making. Additionally, peer-reviewed otology studies (2025) highlight the increasing use of high-resolution tympanic imaging and AI-assisted hearing assessment tools for early identification of conductive and sensorineural hearing loss. Between 2023 and 2025, expanded newborn hearing screening programs and aging population-driven demand have further increased reliance on otologic diagnostic systems in hospitals and specialty clinics.
The World Health Organization, Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Functional Endoscopic Sinus Surgery (FESS), Health Sciences Authority, the Italian National Institute of Statistics (ISTAT), South Korea Food and Drug Administration (KFDA), the European Hearing Instrument Manufacturers Association (EHIMA) are among the primary and secondary sources referred to while preparing the Diagnostic ENT Devices market report.
Table Of Contents
1. Executive Summary
- 1.1 Analyst Market Outlook
- 1.2 Market Attractiveness
2. Diagnostic ENT Market to 2034 Landscape
- 2.1 Overview
- 2.2 Value Chain Analysis
- 2.3 Supply Chain Analysis
- 2.3.1 List of Manufacturers/Suppliers
- 2.3.2 List of Potential Customers (Upto 50)
- 2.4 Porter's Five Force Analysis
- 2.5 PEST Analysis
- 2.6 Import-Export Analysis for Key Countries (As per the nearest HS Code)
- 2.6.1 Import-Export Analysis for Key Countries
- 2.7 Impact of Artificial Intelligence (AI)
- 2.8 Product or Technology Roadmap
- 2.9 Sustainability and ESG Trends
- 2.10 Patent Analysis
- 2.11 Regulatory Framework
3. Competitive Landscape
- 3.1 Company Benchmarking by Key Players
- 3.2 Market Share Analysis, 2025 - By Key Players
- 3.3 Market Concentration
4. Diagnostic ENT Market to 2034 - Key Industry Dynamics
- 4.1 Market Drivers
- 4.2 Market Restraints
- 4.3 Market Opportunities
- 4.4 Future Trends
- 4.5 Impact of Drivers and Restraints
5. Diagnostic ENT Market to 2034 - Global Market Analysis
- 5.1 Diagnostic ENT Market to 2034 Revenue (US$ Million), 2021-2034
- 5.2 Diagnostic ENT Market to 2034 Forecast and Analysis
6. Diagnostic ENT Market to 2034 Revenue Analysis - Type
- 6.1 Diagnostic ENT Market to 2034 Forecasts and Analysis by Type
- 6.1.1 ENT Endoscopes
- 6.1.1.1 Overview
- 6.1.1.2 ENT Endoscopes: Diagnostic ENT Market to 2034 - Revenue, 2021-2034 (US$ Million)
- 6.1.2 ENT Visualization Systems
- 6.1.2.1 Overview
- 6.1.2.2 ENT Visualization Systems: Diagnostic ENT Market to 2034 - Revenue, 2021-2034 (US$ Million)
- 6.1.3 Hearing Screening Devices
- 6.1.3.1 Overview
- 6.1.3.2 Hearing Screening Devices: Diagnostic ENT Market to 2034 - Revenue, 2021-2034 (US$ Million)
- 6.1.1 ENT Endoscopes
7. Diagnostic ENT Market to 2034 Revenue Analysis - Ent Endoscopes
- 7.1 Diagnostic ENT Market to 2034 Forecasts and Analysis by Ent Endoscopes
- 7.1.1 Laryngoscopes
- 7.1.1.1 Overview
- 7.1.1.2 Laryngoscopes: Diagnostic ENT Market to 2034 - Revenue, 2021-2034 (US$ Million)
- 7.1.2 Nasopharyngoscopes
- 7.1.2.1 Overview
- 7.1.2.2 Nasopharyngoscopes: Diagnostic ENT Market to 2034 - Revenue, 2021-2034 (US$ Million)
- 7.1.3 Sinus Endoscopes
- 7.1.3.1 Overview
- 7.1.3.2 Sinus Endoscopes: Diagnostic ENT Market to 2034 - Revenue, 2021-2034 (US$ Million)
- 7.1.1 Laryngoscopes
8. Diagnostic ENT Market to 2034 Revenue Analysis - Application
- 8.1 Diagnostic ENT Market to 2034 Forecasts and Analysis by Application
- 8.1.1 Otology
- 8.1.1.1 Overview
- 8.1.1.2 Otology: Diagnostic ENT Market to 2034 - Revenue, 2021-2034 (US$ Million)
- 8.1.2 Rhinology
- 8.1.2.1 Overview
- 8.1.2.2 Rhinology: Diagnostic ENT Market to 2034 - Revenue, 2021-2034 (US$ Million)
- 8.1.3 Laryngology
- 8.1.3.1 Overview
- 8.1.3.2 Laryngology: Diagnostic ENT Market to 2034 - Revenue, 2021-2034 (US$ Million)
- 8.1.4 Other Applications
- 8.1.4.1 Overview
- 8.1.4.2 Other Applications: Diagnostic ENT Market to 2034 - Revenue, 2021-2034 (US$ Million)
- 8.1.1 Otology
9. Diagnostic ENT Market to 2034 Revenue Analysis - End User
- 9.1 Diagnostic ENT Market to 2034 Forecasts and Analysis by End User
- 9.1.1 Hospitals
- 9.1.1.1 Overview
- 9.1.1.2 Hospitals: Diagnostic ENT Market to 2034 - Revenue, 2021-2034 (US$ Million)
- 9.1.2 Ambulatory Surgical Centers (ASC)
- 9.1.2.1 Overview
- 9.1.2.2 Ambulatory Surgical Centers (ASC): Diagnostic ENT Market to 2034 - Revenue, 2021-2034 (US$ Million)
- 9.1.3 ENT Specialty Clinics
- 9.1.3.1 Overview
- 9.1.3.2 ENT Specialty Clinics: Diagnostic ENT Market to 2034 - Revenue, 2021-2034 (US$ Million)
- 9.1.4 Home Healthcare
- 9.1.4.1 Overview
- 9.1.4.2 Home Healthcare: Diagnostic ENT Market to 2034 - Revenue, 2021-2034 (US$ Million)
- 9.1.5 Other End Users
- 9.1.5.1 Overview
- 9.1.5.2 Other End Users: Diagnostic ENT Market to 2034 - Revenue, 2021-2034 (US$ Million)
- 9.1.1 Hospitals
10. Diagnostic ENT Market to 2034 - Geographical Analysis
- 10.1 North America
- 10.1.1 North America Diagnostic ENT Market to 2034 Overview
- 10.1.2 North America: Diagnostic ENT Market to 2034 Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.1.3 North America: Diagnostic ENT Market to 2034 - By Segmentation
- 10.1.3.1 Type
- 10.1.3.2 Ent Endoscopes
- 10.1.3.3 Application
- 10.1.3.4 End User
- 10.1.4 North America: Diagnostic ENT Market to 2034 Breakdown by Countries
- 10.1.4.1 United States Market
- 10.1.4.1.1 United States: Diagnostic ENT Market to 2034 Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.1.4.1.2 United States: Diagnostic ENT Market to 2034 - By Segmentation
- 10.1.4.1.2.1 Type
- 10.1.4.1.2.2 Ent Endoscopes
- 10.1.4.1.2.3 Application
- 10.1.4.1.2.4 End User
- 10.1.4.2 Canada Market
- 10.1.4.2.1 Canada: Diagnostic ENT Market to 2034 Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.1.4.2.2 Canada: Diagnostic ENT Market to 2034 - By Segmentation
- 10.1.4.2.2.1 Type
- 10.1.4.2.2.2 Ent Endoscopes
- 10.1.4.2.2.3 Application
- 10.1.4.2.2.4 End User
- 10.1.4.3 Mexico Market
- 10.1.4.3.1 Mexico: Diagnostic ENT Market to 2034 Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.1.4.3.2 Mexico: Diagnostic ENT Market to 2034 - By Segmentation
- 10.1.4.3.2.1 Type
- 10.1.4.3.2.2 Ent Endoscopes
- 10.1.4.3.2.3 Application
- 10.1.4.3.2.4 End User
- 10.1.4.1 United States Market
- 10.2 Europe
- 10.2.1 Europe Diagnostic ENT Market to 2034 Overview
- 10.2.2 Europe: Diagnostic ENT Market to 2034 Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.2.3 Europe: Diagnostic ENT Market to 2034 - By Segmentation
- 10.2.3.1 Type
- 10.2.3.2 Ent Endoscopes
- 10.2.3.3 Application
- 10.2.3.4 End User
- 10.2.4 Europe: Diagnostic ENT Market to 2034 Breakdown by Countries
- 10.2.4.1 Germany Market
- 10.2.4.1.1 Germany: Diagnostic ENT Market to 2034 Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.2.4.1.2 Germany: Diagnostic ENT Market to 2034 - By Segmentation
- 10.2.4.1.2.1 Type
- 10.2.4.1.2.2 Ent Endoscopes
- 10.2.4.1.2.3 Application
- 10.2.4.1.2.4 End User
- 10.2.4.2 United Kingdom Market
- 10.2.4.2.1 United Kingdom: Diagnostic ENT Market to 2034 Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.2.4.2.2 United Kingdom: Diagnostic ENT Market to 2034 - By Segmentation
- 10.2.4.2.2.1 Type
- 10.2.4.2.2.2 Ent Endoscopes
- 10.2.4.2.2.3 Application
- 10.2.4.2.2.4 End User
- 10.2.4.3 France Market
- 10.2.4.3.1 France: Diagnostic ENT Market to 2034 Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.2.4.3.2 France: Diagnostic ENT Market to 2034 - By Segmentation
- 10.2.4.3.2.1 Type
- 10.2.4.3.2.2 Ent Endoscopes
- 10.2.4.3.2.3 Application
- 10.2.4.3.2.4 End User
- 10.2.4.4 Italy Market
- 10.2.4.4.1 Italy: Diagnostic ENT Market to 2034 Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.2.4.4.2 Italy: Diagnostic ENT Market to 2034 - By Segmentation
- 10.2.4.4.2.1 Type
- 10.2.4.4.2.2 Ent Endoscopes
- 10.2.4.4.2.3 Application
- 10.2.4.4.2.4 End User
- 10.2.4.5 Spain Market
- 10.2.4.5.1 Spain: Diagnostic ENT Market to 2034 Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.2.4.5.2 Spain: Diagnostic ENT Market to 2034 - By Segmentation
- 10.2.4.5.2.1 Type
- 10.2.4.5.2.2 Ent Endoscopes
- 10.2.4.5.2.3 Application
- 10.2.4.5.2.4 End User
- 10.2.4.6 Rest of Europe Market
- 10.2.4.6.1 Rest of Europe: Diagnostic ENT Market to 2034 Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.2.4.6.2 Rest of Europe: Diagnostic ENT Market to 2034 - By Segmentation
- 10.2.4.6.2.1 Type
- 10.2.4.6.2.2 Ent Endoscopes
- 10.2.4.6.2.3 Application
- 10.2.4.6.2.4 End User
- 10.2.4.1 Germany Market
- 10.3 Asia Pacific
- 10.3.1 Asia Pacific Diagnostic ENT Market to 2034 Overview
- 10.3.2 Asia Pacific: Diagnostic ENT Market to 2034 Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.3.3 Asia Pacific: Diagnostic ENT Market to 2034 - By Segmentation
- 10.3.3.1 Type
- 10.3.3.2 Ent Endoscopes
- 10.3.3.3 Application
- 10.3.3.4 End User
- 10.3.4 Asia Pacific: Diagnostic ENT Market to 2034 Breakdown by Countries
- 10.3.4.1 China Market
- 10.3.4.1.1 China: Diagnostic ENT Market to 2034 Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.3.4.1.2 China: Diagnostic ENT Market to 2034 - By Segmentation
- 10.3.4.1.2.1 Type
- 10.3.4.1.2.2 Ent Endoscopes
- 10.3.4.1.2.3 Application
- 10.3.4.1.2.4 End User
- 10.3.4.2 Japan Market
- 10.3.4.2.1 Japan: Diagnostic ENT Market to 2034 Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.3.4.2.2 Japan: Diagnostic ENT Market to 2034 - By Segmentation
- 10.3.4.2.2.1 Type
- 10.3.4.2.2.2 Ent Endoscopes
- 10.3.4.2.2.3 Application
- 10.3.4.2.2.4 End User
- 10.3.4.3 India Market
- 10.3.4.3.1 India: Diagnostic ENT Market to 2034 Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.3.4.3.2 India: Diagnostic ENT Market to 2034 - By Segmentation
- 10.3.4.3.2.1 Type
- 10.3.4.3.2.2 Ent Endoscopes
- 10.3.4.3.2.3 Application
- 10.3.4.3.2.4 End User
- 10.3.4.4 Australia Market
- 10.3.4.4.1 Australia: Diagnostic ENT Market to 2034 Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.3.4.4.2 Australia: Diagnostic ENT Market to 2034 - By Segmentation
- 10.3.4.4.2.1 Type
- 10.3.4.4.2.2 Ent Endoscopes
- 10.3.4.4.2.3 Application
- 10.3.4.4.2.4 End User
- 10.3.4.5 South Korea Market
- 10.3.4.5.1 South Korea: Diagnostic ENT Market to 2034 Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.3.4.5.2 South Korea: Diagnostic ENT Market to 2034 - By Segmentation
- 10.3.4.5.2.1 Type
- 10.3.4.5.2.2 Ent Endoscopes
- 10.3.4.5.2.3 Application
- 10.3.4.5.2.4 End User
- 10.3.4.6 Rest of Asia Pacific Market
- 10.3.4.6.1 Rest of Asia Pacific: Diagnostic ENT Market to 2034 Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.3.4.6.2 Rest of Asia Pacific: Diagnostic ENT Market to 2034 - By Segmentation
- 10.3.4.6.2.1 Type
- 10.3.4.6.2.2 Ent Endoscopes
- 10.3.4.6.2.3 Application
- 10.3.4.6.2.4 End User
- 10.3.4.1 China Market
- 10.4 Middle East and Africa
- 10.4.1 Middle East and Africa Diagnostic ENT Market to 2034 Overview
- 10.4.2 Middle East and Africa: Diagnostic ENT Market to 2034 Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.4.3 Middle East and Africa: Diagnostic ENT Market to 2034 - By Segmentation
- 10.4.3.1 Type
- 10.4.3.2 Ent Endoscopes
- 10.4.3.3 Application
- 10.4.3.4 End User
- 10.4.4 Middle East and Africa: Diagnostic ENT Market to 2034 Breakdown by Countries
- 10.4.4.1 Saudi Arabia Market
- 10.4.4.1.1 Saudi Arabia: Diagnostic ENT Market to 2034 Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.4.4.1.2 Saudi Arabia: Diagnostic ENT Market to 2034 - By Segmentation
- 10.4.4.1.2.1 Type
- 10.4.4.1.2.2 Ent Endoscopes
- 10.4.4.1.2.3 Application
- 10.4.4.1.2.4 End User
- 10.4.4.2 South Africa Market
- 10.4.4.2.1 South Africa: Diagnostic ENT Market to 2034 Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.4.4.2.2 South Africa: Diagnostic ENT Market to 2034 - By Segmentation
- 10.4.4.2.2.1 Type
- 10.4.4.2.2.2 Ent Endoscopes
- 10.4.4.2.2.3 Application
- 10.4.4.2.2.4 End User
- 10.4.4.3 United Arab Emirates Market
- 10.4.4.3.1 United Arab Emirates: Diagnostic ENT Market to 2034 Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.4.4.3.2 United Arab Emirates: Diagnostic ENT Market to 2034 - By Segmentation
- 10.4.4.3.2.1 Type
- 10.4.4.3.2.2 Ent Endoscopes
- 10.4.4.3.2.3 Application
- 10.4.4.3.2.4 End User
- 10.4.4.4 Rest of Middle East and Africa Market
- 10.4.4.4.1 Rest of Middle East and Africa: Diagnostic ENT Market to 2034 Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.4.4.4.2 Rest of Middle East and Africa: Diagnostic ENT Market to 2034 - By Segmentation
- 10.4.4.4.2.1 Type
- 10.4.4.4.2.2 Ent Endoscopes
- 10.4.4.4.2.3 Application
- 10.4.4.4.2.4 End User
- 10.4.4.1 Saudi Arabia Market
- 10.5 South and Central America
- 10.5.1 South and Central America Diagnostic ENT Market to 2034 Overview
- 10.5.2 South and Central America: Diagnostic ENT Market to 2034 Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.5.3 South and Central America: Diagnostic ENT Market to 2034 - By Segmentation
- 10.5.3.1 Type
- 10.5.3.2 Ent Endoscopes
- 10.5.3.3 Application
- 10.5.3.4 End User
- 10.5.4 South and Central America: Diagnostic ENT Market to 2034 Breakdown by Countries
- 10.5.4.1 Brazil Market
- 10.5.4.1.1 Brazil: Diagnostic ENT Market to 2034 Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.5.4.1.2 Brazil: Diagnostic ENT Market to 2034 - By Segmentation
- 10.5.4.1.2.1 Type
- 10.5.4.1.2.2 Ent Endoscopes
- 10.5.4.1.2.3 Application
- 10.5.4.1.2.4 End User
- 10.5.4.2 Argentina Market
- 10.5.4.2.1 Argentina: Diagnostic ENT Market to 2034 Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.5.4.2.2 Argentina: Diagnostic ENT Market to 2034 - By Segmentation
- 10.5.4.2.2.1 Type
- 10.5.4.2.2.2 Ent Endoscopes
- 10.5.4.2.2.3 Application
- 10.5.4.2.2.4 End User
- 10.5.4.3 Rest of South and Central America Market
- 10.5.4.3.1 Rest of South and Central America: Diagnostic ENT Market to 2034 Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.5.4.3.2 Rest of South and Central America: Diagnostic ENT Market to 2034 - By Segmentation
- 10.5.4.3.2.1 Type
- 10.5.4.3.2.2 Ent Endoscopes
- 10.5.4.3.2.3 Application
- 10.5.4.3.2.4 End User
- 10.5.4.1 Brazil Market
11. Diagnostic ENT Market to 2034 Industry Landscape
12. Diagnostic ENT Market to 2034 - Key Company Profiles
- 12.1 Sonova Holding AG
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 GN Store Nord AS
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 WS Audiology AS
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
- 12.4 Olympus Corp
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
- 12.5 Karl Storz SE & Co KG
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
- 12.6 Demant AS
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
- 12.7 Cochlear Ltd
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
- 12.8 Stryker Corp
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
- 12.9 Smith & Nephew Plc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
- 12.10 Medtronic Plc
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
13. List of Additional Companies Analyzed
- 13.1 List of Additional Companies Analyzed
14. Appendix
- 14.1 Glossary
- 14.2 Research Methodology and Approach
- 14.2.1 Secondary Research
- 14.2.2 Primary Research
- 14.2.3 Market Estimation Approach
- 14.2.3.1 Supply Side Analysis
- 14.2.3.2 Demand Side Analysis
- 14.2.4 Research Assumptions and Limitations
- 14.2.5 Currency Conversion
- 14.3 About The Insight Partners
- 14.4 Market Intelligence Cloud
